Identifying Mechanisms of Resistance to ALK Tyrosine Kinase Inhibitors Using Analysis of Circulating Tumor DNA
- PMID: 32216941
- DOI: 10.1016/j.jtho.2019.12.116
Identifying Mechanisms of Resistance to ALK Tyrosine Kinase Inhibitors Using Analysis of Circulating Tumor DNA
Comment on
-
ALK Mutation Status Before and After Alectinib Treatment in Locally Advanced or Metastatic ALK-Positive NSCLC: Pooled Analysis of Two Prospective Trials.J Thorac Oncol. 2020 Apr;15(4):601-608. doi: 10.1016/j.jtho.2019.10.015. Epub 2019 Nov 9. J Thorac Oncol. 2020. PMID: 31712133
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical